Activation and repression of glucose-stimulated ChREBP requires the concerted action of multiple domains within the MondoA conserved region

• Published in: American journal of physiology: endocrinology and metabolism Vol. 299; no. 4; pp. E665 - E674
• Main Authors: Davies, Michael N, O'Callaghan, Brennon L, Towle, Howard C
• Format: Journal Article
• Language: English
• Published: United States American Physiological Society 01.10.2010
• Subjects: Amino acids; Animals; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors - antagonists & inhibitors; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors - genetics; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors - metabolism; Binding sites; Binding, Competitive; Carbohydrates; Cell Line; Conserved Sequence; Electrophoretic Mobility Shift Assay; Glucose; Glucose - metabolism; Luciferases, Renilla - chemistry; Luciferases, Renilla - genetics; Mutagenesis, Insertional; Mutagenesis, Site-Directed; Mutation; Plasmids - metabolism; Point Mutation; Protein Structure, Tertiary; Proteins; Rats; Response Elements; Transfection
• ISSN: 0193-1849; 1522-1555
• DOI: 10.1152/ajpendo.00349.2010

Carbohydrate response element-binding protein (ChREBP) is a glucose-dependent transcription factor that stimulates the expression of glycolytic and lipogenic genes in mammals. Glucose regulation of ChREBP has been mapped to its conserved NH(2)-terminal region of 300 amino acids, designated the MondoA conserved region (MCR). Within the MCR, five domains (MCR1-5) have a particularly high level of conservation and are likely to be important for glucose regulation. We carried out a large-scale deletion and substitution mutational analysis of the MCR domain of ChREBP. This analysis revealed that MCRs 1-4 function in a concerted fashion to repress ChREBP activity in basal (nonstimulatory) conditions. Deletion of the entire MCR1-4 segment or the combination of four specific point mutations located across this region leads to a highly active, glucose-independent form of ChREBP. However, deletion of any individual MCR domain and the majority of point mutations throughout MCR1-4 rendered ChREBP inactive. These observations suggest that the MCR1-4 region interacts with an additional coregulatory factor required for activation. This possibility is supported by the observation that the MCR1-4 region can compete for activity with wild-type ChREBP in stimulatory conditions. In contrast, mutations in the MCR5 domain result in increased activity, suggesting that this domain may be the target of intramolecular repression in basal conditions. Thus, the MCR domains act in a complex and coordinated manner to regulate ChREBP activity in response to glucose.